Adorial

High Wycombe, United Kingdom Founded: 2014 • Age: 12 yrs Acquired By C4X Discovery
Proprietary in silico genomics platform is utilized for drug discovery.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Adorial

Adorial is a company based in High Wycombe (United Kingdom) founded in 2014 was acquired by C4X Discovery in March 2016. Adorial operates in a competitive market with competitors including Helix, Benchling, NantHealth, Genuity Science and Inpharmatica, among others.

  • Headquarter High Wycombe, United Kingdom
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Adorial Ltd
  • Date of Incorporation 15 Dec, 2014
  • Jurisdiction MANCHESTER, ENGLAND
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$1.27 K (USD)
    88
    as on Jul 31, 2017
  • EBITDA
    -$1.27 K (USD)
    88
    as on Jul 31, 2017
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    C4X Discovery

    (Mar 01, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Adorial

Premium access

Detailed funding history for Adorial

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Adorial

Adorial has secured backing from 1 investor. Prominent investors backing the company include C4X Discovery.

All
Investor Description Founded Year Domain Location
Developer of optimized drug discovery and design services
Locked Locked Locked
Premium access

Investor details for Adorial

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Adorial

Investments
Premium access

Investment portfolio details for Adorial

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Adorial

Premium access

Detailed financials for Adorial

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Adorial Comparisons

Adorial Primary company
Description
Proprietary in silico genomics platform is utilized for drug...
Location
High Wycombe, United Kingdom
Founded Year
2014
Annual Revenue
Not available
Net Profit
-$1.27 K (USD)
EBITDA
-$1.27 K (USD)
Employees
Not available
Premium access

Peer comparison for Adorial

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Adorial

Adorial operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, NantHealth, Genuity Science and Inpharmatica, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genomic database for clinical research is provided.
Locked Locked Locked
Cloud-based bioinformatics platform is offered for biotech research.
Locked Locked Locked
Bioinformatics platforms are provided for cancer treatment identification.
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Locked Locked Locked
Developer of predictive informatics based platform for drug discovery
Locked Locked Locked
Bioinformatics platform is provided for biomarkers and drug discovery.
Premium access

Detailed competitors of Adorial

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Adorial

Premium access

Complete news archive for Adorial

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Adorial

Adorial was founded in 2014.

Adorial is headquartered in High Wycombe, United Kingdom. It is registered at High Wycombe, Buckinghamshire, United Kingdom.

Adorial is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets. Adorial was spun-out from PGXIS in 2015. Offers a technology platform, Taxonomy3 for the analysis of genetic dataset and will allow broad screening for gene-gene interactions. Adorial identified 18 novel drug targets causally related to Rheumatoid Arthritis RA) using Taxonomy3. These have not been identified in any previous published genetic analysis of RA,.

Adorial's top competitors include Helix, NantHealth and Benchling.

Adorial has 1 investor. Key investors include C4X Discovery.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available